Role of experience and oscillations in transforming a rate code into a temporal codeMinesh P. Mehta, Melissa Wilson, A. K. Lee|Nature|2002Cited by 657
Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgeryAmparo Wolf, Douglas Kondziolka, Svetlana Kvint et al.|Journal of neurosurgery|2017Cited by 71
Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastasesAmparo Wolf, Douglas Kondziolka, Sayyad Yaseen Zia et al.|Journal of Neuro-Oncology|2016Cited by 56
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signalingR. P. Tripathi, Rina Plattner, Zulong Liu et al.|Nature Communications|2020Cited by 51
Preliminary results of a phase II study of alrizomadlin (APG-115), a novel, small-molecule MDM2 inhibitor, in combination with pembrolizumab in patients (pts) with unresectable or metastatic melanoma or advanced solid tumors that have failed immuno-oncologic (I-O) drugs.Anthony W. Tolcher, Yifan Zhai, James A. Reeves et al.|Journal of Clinical Oncology|2021Cited by 23